We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+0.3%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$13.9B
AUM Growth
-$512M
Cap. Flow
-$427M
Cap. Flow %
-3.07%
Top 10 Hldgs %
13.98%
Holding
2,837
New
70
Increased
591
Reduced
1,041
Closed
180

Sector Composition

Rank Sector Weight
1 Technology 13.37%
2 Financials 12.9%
3 Healthcare 12.13%
4 Energy 11.84%
5 Industrials 10.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOOM
1676
DELISTED
XOOM CORP COM
XOOM
$532K ﹤0.01%
24,221
UBNK
1677
DELISTED
United Financial Bancorp, Inc.
UBNK
$529K ﹤0.01%
41,710
-2
-0% -$25
ARII
1678
DELISTED
American Railcar Industries, Inc.
ARII
$527K ﹤0.01%
7,126
+78
+1% +$5.75K
SMP icon
1679
Standard Motor Products
SMP
$877M
$526K ﹤0.01%
15,265
TBRG
1680
DELISTED
TruBridge
TBRG
$526K ﹤0.01%
9,149
ENSG icon
1681
The Ensign Group
ENSG
$10.6B
$525K ﹤0.01%
32,252
-5,287
-14% -$83.7K
MTRX icon
1682
Matrix Service
MTRX
$330M
$525K ﹤0.01%
21,762
AVIV
1683
DELISTED
AVIV REIT INC COM STK (MD)
AVIV
$525K ﹤0.01%
19,906
-405
-2% -$11.4K
STC icon
1684
Stewart Information Services
STC
$2B
$524K ﹤0.01%
17,840
NTK
1685
DELISTED
NORTEK INC COM NEW (DE)
NTK
$524K ﹤0.01%
7,040
ZLTQ
1686
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$523K ﹤0.01%
23,101
LXU icon
1687
LSB Industries
LXU
$711M
$521K ﹤0.01%
18,957
ULTA icon
1688
Ulta Beauty
ULTA
$22.2B
$521K ﹤0.01%
4,412
-33
-0.7% -$3.28K
MANT
1689
DELISTED
Mantech International Corp
MANT
$521K ﹤0.01%
19,329
ADAM
1690
Adamas Trust
ADAM
$913M
$520K ﹤0.01%
17,991
+2,670
+17% +$83.1K
INFI
1691
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$520K ﹤0.01%
38,742
NX icon
1692
Quanex
NX
$1B
$519K ﹤0.01%
28,674
STRA icon
1693
Strategic Education
STRA
$1.81B
$519K ﹤0.01%
8,665
-1,221
-12% -$68.9K
MDVN
1694
DELISTED
MEDIVATION, INC.
MDVN
$519K ﹤0.01%
10,500
-78
-0.7% -$3.31K
MTRN icon
1695
Materion
MTRN
$5.9B
$518K ﹤0.01%
16,880
TMP icon
1696
Tompkins Financial
TMP
$1.44B
$518K ﹤0.01%
11,741
DMND
1697
DELISTED
DIAMOND FOODS, INC.
DMND
$518K ﹤0.01%
18,095
LAB icon
1698
Standard BioTools
LAB
$312M
$517K ﹤0.01%
21,122
+744
+4% +$20.9K
NSP icon
1699
Insperity
NSP
$1.92B
$517K ﹤0.01%
37,824
PGEN icon
1700
Precigen
PGEN
$2.32B
$517K ﹤0.01%
29,095

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2014 Portfolio in Review

As of Q3 2014, Metropolitan Life Insurance Company (MetLife) held 2,837 positions worth $13.9B, down 3.6% from $14.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Metropolitan Life Insurance Company (MetLife) withdrew a net $427M in Q3 2014, closing 180 positions and reducing 1,041 holdings. Its most notable exit was Accenture, an estimated $31.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in Monsanto Co worth $35.2M.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2014 buy was Monsanto Co: 313,199 shares worth $35.2M.
  • Metropolitan Life Insurance Company (MetLife) added most to Microsoft in Q3 2014, an estimated $14M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $22.5M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Accenture in Q3 2014, selling an estimated $31.6M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 14% of its $13.9B portfolio in Q3 2014.
  • Metropolitan Life Insurance Company (MetLife) opened 70 new positions and closed 180 in Q3 2014.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 3.6% quarter-over-quarter to $13.9B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2014, filed 10 Nov 2014.